The patient’s bravery was praised by Dr. Michael Curtis, CEO of eGenesis, as a real pioneer that made possible this significant advancement in science and transplant treatment.
Even though the procedure is a huge accomplishment, experts warn that additional study is necessary to completely comprehend the efficacy and long-term results of kidney transplants from pigs in people.
There is hope, nevertheless, that these transplants may eventually render dialysis unnecessary and offer patients in need of organ transplants a more long-term answer.
The story of Mr. Slayman, who had multiple dialysis treatments before obtaining a kidney from a genetically modified pig, demonstrates how medical innovation has the power to change and save lives.
It is hoped that as transplant therapy advances, more people will be able to take advantage of these ground-breaking discoveries, similar to Mr. Slayman.
Other stories
-
Ghana’s public debt reaches GH₵610 billion, or 72.5% of GDP.
-
The Fed signals an impending reduction but keeps interest rates unchanged.
-
“Nonprime” is a catchy term for the resurgence of high-risk mortgages.
-
CEO of Tesla says trade obstacles won’t stop Chinese EV companies from “demolishing” competitors.
-
GTP unveils the Nustyle Ghana Month line